$90.360
-3.145 (-3.48%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
SYRE 相似圖表分析預測
Alphio's SYRE stock price prediction model matches the current Spyre Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $91.13 (+0.85%). The 1-week path is $94.14 (+4.18%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
該買進 Spyre Therapeutics Inc 股票嗎？
Spyre Therapeutics Inc is currently not a good buy. The stock is trading at $90.36, with a 5-day change of -15.15% and an RSI of 16.467, indicating it is oversold. Despite a strong year-to-date change of +195.49% and a one-year change of +443.36%, the recent insider selling and downgrades in analyst price targets suggest caution. The main risk is the significant net losses, with a reported net income of -$69 million for Q1 2026, which raises concerns about sustainability.
SYRE 股價於 Friday 收在 $90.36，此前下跌 -3.48%
Spyre Therapeutics Inc (SYRE) last closed at $90.36, losing -3.48%. These facts feed the 1-day and 1-week SYRE price prediction above.
預測驅動因素
Spyre Therapeutics Inc（SYRE）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
相似圖表形態
近期走勢與 SYRE 最接近的股票，依相似度排序。
SYRE 季節性分析
Historically the probability of a positive August return for SYRE is 66.67%. December offers the highest probability of a positive month at 100.00%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。